Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Livongo Health Inc. LVGO

Livongo Health Inc provides a data science and technology enabled platform for detection of diabetes. Its additional solutions include Livongo for Hypertension, Livongo for Prediabetes and Weight Management, and Livongo for Behavioral Health by myStrength. The company's client comprise of employers, health plans, government entities, and labor unions. Its operations are primarily located in the United States.


NDAQ:LVGO - Post by User

Post by drbob512on May 29, 2020 8:28pm
62 Views
Post# 31090645

Today it was reported LVGO

Today it was reported LVGOinsiders recently bought some shares. Seemed it was 2 insiders & the # of shares bought was much less than what i saw was sold by insiders recently. Fwiw cuz i still think their business plan & execution of it is as good as it gets. Fyi 34M Americans have diabetes, 500k Americans develop diabetes every year, 140M Americans have a chronic health problem, and LVFO has penetrated only about 1% of the U.S. diabetes population. Hypertension, weight mgmt & behavioral disorders aka psychological- emotional problems are all being targeted by Livongo. While growth in rev was 114% for 1st qtr (y/y) & currwnt estimates for 2nd qtr range from 70%-90%, i have a feeling it could end up being above those estimates, perhaps 95%-110% even tho this company is much larger than a year ago which usually makes it harder to keep up growth rates. But their sales could be only the tip of the iceberg. Remember Americans are getting bigger (1/3 fat, 1/3 obese) and have high blood pressure, & anxiety/depression. Future potential is almost endless, imho.
<< Previous
Bullboard Posts
Next >>